Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carotid sinus nerve stimulation, clinical applications and case report.

Journal of the Iowa Medical Society·1972
Same author

Preoperative evaluation of the cardiac patient.

Journal of the Iowa Medical Society·1971
Same author

Congestive heart failure in acute myocardial infarction.

The Journal of the Indiana State Medical Association·1970
Same author

Cardiogenic shock in acute myocardial infarction.

The Journal of the Indiana State Medical Association·1968
Same author

Cardiac pacemakers.

The Journal of the Indiana State Medical Association·1967
Same author

Ominous arrhythmias following myocardial infarction.

Texas medicine·1967
Same journal

MEDICAL Society of New Jersey, 184th Annual Meeting, Atlantic City, New Jersey, May 22-24, 1950.

The Journal of the Medical Society of New Jersey·2014
Same journal

Medical Service Administration of New Jersey; Medical Surgical Plan of New Jersey.

The Journal of the Medical Society of New Jersey·2010
Same journal

Asymptomatic congenital diaphragmatic hernia; a case report.

The Journal of the Medical Society of New Jersey·2010
Same journal

The treatment of amebiasis.

The Journal of the Medical Society of New Jersey·2010
Same journal

Masking of mastoiditis symptoms by penicillin.

The Journal of the Medical Society of New Jersey·2010
Same journal

The wart and its treatment.

The Journal of the Medical Society of New Jersey·2010
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
09:04

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products

Published on: September 9, 2016

Quinidine, a dangerous ally

A D DENNISON

    The Journal of the Medical Society of New Jersey
    |March 19, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    QUINIDINES

    More Related Videos

    Green Synthesis of Quinoline-Based Ionic Liquid
    05:59

    Green Synthesis of Quinoline-Based Ionic Liquid

    Published on: September 27, 2024

    Related Experiment Videos

    Last Updated: Jun 15, 2026

    A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
    09:04

    A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products

    Published on: September 9, 2016

    Green Synthesis of Quinoline-Based Ionic Liquid
    05:59

    Green Synthesis of Quinoline-Based Ionic Liquid

    Published on: September 27, 2024